Bonifazi, M., Tramacere, I., Pomponio, G., Gabrielli, B., Avvedimento, E.V., La Vecchia, C., Negri, E. and Gabrielli, A. (2013) Systemic Sclerosis (Scleroderma) and Cancer Risk: Systematic Review and Meta-Analysis of Observational Studies. Rheumatology, 52, 143-154. http://dx.doi.org/10.1093/rheumatology/kes303

has been cited by the following article:

• TITLE: Anti-RNA Polymerase III Antibodies in Systemic Sclerosis

  AUTHORS: Andrew Kelly, Chris T. Derk

  KEYWORDS: Autoantibodies, Systemic Sclerosis, Scleroderma, Anti-RNA Polymerase III, Cancer

  JOURNAL NAME: Open Journal of Rheumatology and Autoimmune Diseases, Vol.5 No.3, August 19, 2015

  ABSTRACT: Anti-RNA Polymerase III has been recognized as an important autoantibody in Systemic Sclerosis and it is now included in the 2013 ACR/EULAR classification criteria for Systemic Sclerosis. With this manuscript we attempt to review the current data on anti-RNA polymerase II as it relates to Systemic Sclerosis.